Peer-Reviewed Articles

1989 through 1995

Privitera MD, Homan RW, Ludden TM, Peck CC, Vasko MR.  Clinical utility of A Bayesian dosing program for phenytoin.  Therapeutic Drug Monitoring 1989;11:285-294.

Privitera MD.  Dosing accuracy of antiepileptic drug regimens as determined by serum concentrations in outpatient epilepsy clinic patients. Therapeutic Drug Monitoring 1989;11; 647-51.

Liwnicz BH, Leach JS, Yeh HS, Privitera MD.  Pericyte degeneration and basement membrane thickening of cerebral micro vessels in complex partial seizures: electron microscopic study of surgically removed tissue.  Neurosurgery 1990;26:409-420.

Jacobson GP, Privitera MD, Neils JR, Yeh HS.  The effects of anterior temporal lobectomy on the middle latency auditory evoked potential.  Electroenceph Clin Neurophysiol 1990;75:230-241.

Privitera MD, Quinlan JG, Yeh HS.  Interictal spike detection comparing subdural and depth electrodes.  Electroenceph Clin Neurophysiol 1990;76:379-387.

Privitera MD, Morris GL, Gilliam F.  Postictal language assessment and lateralization of complex partial seizures.  Ann Neurol 1991;30:391-396.

Yeh HS, Privitera MD.  Secondary epileptogenesis in cerebral arteriovenous malformations.  Arch Neurol 1991; 48:1122-1124.

Privitera MD.  Clinical rules for phenytoin dosing.  Annals of Pharmacotherapy 1993; 27:1169-1173.

Privitera MD, Hoffman M, Moore JL, Jester D.  EEG detection of nontonic-clonic status epilepticus in patients with altered consciousness.  Epilepsy Research 1994; 18:155-166.

Privitera MD, Treiman DM, Pledger GW, Sahlroot JT, Handforth A, Linde MS, France CR, Cereghino JJ, McCutchen CB, Wood JH.  Dezinamide for partial seizures: Results of an n-of-1 design trial.  Neurology 1994; 44:1453-1458.

Jooma R, Yeh HS, Privitera MD, Rigrish D, Gartner M.  Seizure control and extent of mesial temporal resection.  Acta Neurochirurgica 1995; 133:44-49.

Jooma R, Yeh HS, Privitera MD, Garner M.  Lesionectomy versus electrophysiologically guided resection for temporal lobe tumors manifesting with complex partial seizures.  J Neurosurg 1995; 83:231-236.

Devinsky O, et al and the Intravenous Valproate Study Team (M. Privitera).  Safety of intravenous valproate.  Ann Neurol 1995;.39:670-674.

1996 through 2000

Privitera MD, Fincham R, Penry JK, Reife R, Kramer L, Pledger G, Karim R, and theTopiramate YE Study Group.  Topiramate placebo-controlled, dose-ranging trial inrefractory partial epilepsy using 600-, 800-, and 1000-mg daily dosages.  Neurology1996; 46:1678-1683.

Arnold L, Privitera MD.  Psychopathology and trauma in epileptic and psychogenic seizure patients.  Psychosomatics 1996; 37:438-443.

Privitera MD, Welty TE.  Acute phenytoin toxicity followed by seizure breakthrough from a ticlopidine-phenytoin interaction.  Arch Neurol 1996; 53:1191-1192.

Privitera MD, Kohler C, Cahill W, Yeh HS.  Postictal language dysfunction in patients with right or bilateral hemispheric language localization.  Epilepsia 1996; 37:936-941.

Arnold L, Privitera MD.  Psychopathology and trauma in epileptic and psychogenic seizure patients (letter). Psychosomatics 1996; 37:438-443.

Ficker DM, Westmoreland BF, Sharbrough FW.  Epileptiform abnormalities in hepatic encephalopathy. J. Clin. Neurophysiol 1997; 14:230-234

Privitera MD. Topiramate: A new antiepileptic drug. Ann Pharmacother 1997; 31:1164-1173.

Welty T, Privitera MD.  Increased seizure frequency following felbamate discontinuation.  Arch Neurology 1998;55:641-645.

Warner A, Privitera MD, Bates D.  Standards of laboratory practice: Antiepileptic drug monitoring.  Clinical Chemistry 1998;44(5):1085-95.

Ficker DM, Cascino GD, Clements IP. A case of cardiac asystole masquerading as temporal lobe epilepsy. Mayo Clin Proc 1998;73:784-786.

Ficker DM, So EL, Shen WK, Annegers JF, O’Brien PC, Cascino GD, Belau PG. Population-based study of the incidence of sudden unexplained death in epilepsy. Neurology 1998;51:1270-1274.

Fleck DE, Berch DB, Shear PK, Schefft BK, Privitera MD, Strakowski SM.  Directed Forgetting Deficits in Patients with Temporal Lobe Epilepsy: An Information Processing Perspective.  JINS 1999;5:549-555.

Ficker DM, So EL, Mosewich RK, Cascino GD, Sharbrough FW. Improvement and deterioration of seizure control during the postsurgical course of epilepsy surgery patients. Epilepsia, 1999;40:62-67.

Gidal B, Privitera MD, Sheth R, Gilman J.  Vigabatrin in Seizure Disorders.  Annals Pharmacotherapy 1999;33:1277-86.

McLean MJ, Morrell MJ, Willmore LJ, Privitera MD, Faught RE, Holmes GL, Magnus-Miller L, Bernstein P, Rose-Legatt A.  Safety and tolerability of Gabapentin as Adjunctive Therapy in a Large, Multicenter Study.  Epilepsia 1999; 40(7):965-972.

Privitera MD, Yeh HS, Blisard K, Sanchez N.  Detection of epileptogenic focal cortical dysplasia by depth not subdural electrodes.  Neurosurgical Review 2000, 23(1):0049 – 0051.

Szaflarski JP, Ficker DM, Cahill WT, Privitera MD.  Four-year incidence of psychogenic nonepileptic seizures in adults in Hamilton County, OH.  Neurology 2000; 55:1561-1563.

2001 through 2005

Biton V, Edwards KR, Montouris GD, Sackellares JC, Harden CL, Kamin M, Topiramate TPS-TR Study Group (Privitera MD).  Topiramate titration and tolerability.  Neurology, 2001; 35:173-179.

Marson AG, Hutton JL, Leach JP, Castillo S, Schmidt D, White S, Chaisewikul R, Privitera M, Chadwick DW.  Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review.  Epilepsy Res. 2001 Sep;46(3):259-70.

Chaisewikul R, Privitera MD, Hutton JL, Marson AG.  Levetiracetam add-on for drug-resistant localization related (partial) epilepsy (Cochrane Review).  Cochrane Database Syst Rev. 2001;1:CD001901.

Privitera M, Welty TE, Ficker DM, Welge J.  Vagus nerve stimulation for partial seizures (Cochrane Review).  Cochrane Database Syst Rev 2002;(1):CD002896.

Welty TE, Gidal BE, Ficker DM, Privitera MD.  Levetiracetam:  a different approach to the pharmacotherapy of epilepsy.  Ann Pharmacother, 2002; 36:296-304.

Szaflarski JP, Hughes C, Szaflarski M, Ficker DM, Cahill WT, Li M, Privitera MD. Quality of Life in Psychogenic Nonepileptic Seizures.  Epilepsia, 2003; 44(2): 236-242.

Dulay MF, Schefft BK, Testa SM, Fargo JD, Privitera MD, Yeh HS.  What does the Family Pictures subtest of the Wechsler Memory Scale-III measure?  Insight gained from patients evaluated for epilepsy surgery.  The Clinical Neuropsychologist 2002;16(4):452-462.

Privitera M, Brodie M, Mattson R, Chadwick D, Neto W, Wang S, et al.  Topiramate, carbamazepine and valproate monotherapy:  a double-blind comparison in the spectrum of newly diagnosed epilepsy.  Acta Neurol Scand, 2003; 107:165-175.

Szaflarski JP, Szaflarski M, Hughes C, Ficker DM, Cahill WT, Privitera MD. Psychopathology and Quality of Life:  Psychogenic Non-Epileptic Seizures versus Epilepsy.  Medical Science Monitor, 2003;9(4):CR113-118.

Privitera M.  Phase IV Trials:  A Wolf in Sheep’s Clothing?  Ann Pharmacother 2003, May:(37):741-743.

Rose AB, McCabe PH, Gilliam FG, Smith BJ, Boggs JG, Ficker DM, Moore JL, Passaro EA, Bazil CW. Occurrence of seizure clusters and status epilepticus during inpatient video-EEG monitoring.  Neurology 2003; 60: 975-8.

Schefft BK, Testa SM, Dulay MF, Privitera MD, Yeh HS.  Preoperative assessment of confrontation naming ability and interictal paraphasia production in unilateral temporal lobe epilepsy.  Epilepsy & Behavior 2003: (4)161-168.

Kanner AM, Wuu J, Faught E, Tatum W, Fix A, French JA, The PADS Investigators (Privitera M).  A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events.  Epilepsy & Behavior 2003; (4):548-552.

Tang Y, Lu A, Ran R, Aronowc BJ, Schorryd EK, Hopkind RJ, Gilbert DL, Glauser TA, Hershey AD, Richtand NW, Privitera M, Dalvi A, Sahay A, Szaflarski JP, Ficker DM, Ratner N, Sharp FR.  Human blood genomics:  distinct profiles for gender, age and neurofibromatosis type 1.  Molecular Brain Research, Oct 2003: online

Tang Y, Glauser TA, Gilbert DL, Hershey AD, Privitera MD, Ficker DM, Szaflarski JP, Sharp FR.  Valproic acid blood genomic expression patterns in children with epilepsy – a pilot study.  Acta Neurol Scand 2003: DOI: 10.1046/j.1600-0404.2003.00253.x.

Testa M, Schefft BK, Privitera MD, Yeh HS.  Warrington’s Recognition Memory for Faces:  Interpretive Strategy and Diagnostic Utility in Temporal Lobe Epilepsy.  Epilepsy & Behavior 2004; 5(2):236-243.

Szaflarski JP, Holland SK, Schmithorst VJ, Dunn RS, Privitera MD.  High-resolution functional MRI at 3 T in healthy and epilepsy subjects: hippocampal activation with picture encoding task.  Epilepsy and Behavior 2004; 5(2):244-252.

Goldberg-Stern H, Gadoth N, Cahill W, Privitera M. Language dysfunction after frontal lobe partial seizures. Neurology, 2004; 62(9):1637-1638.

Dulay MF, Schefft BK, Fargo JD, Privitera MD, Yeh HS.  Severity of depressive symptoms, hippocampal sclerosis, auditory memory, and side of seizure focus in temporal lobe epilepsy.  Epilepsy and Behavior. 2004 Aug;5(4):522-31.

Cavitt J, Privitera M. Levetiracetam induces a rapid and sustained reduction of generalized spike-wave and clinical absence.  Arch Neurol, 2004; Oct; 61(10):1604-7.

Privitera M, Ficker DM.  Assessment of adverse events and quality of life in epilepsy: design of a new community-based trial.  Epilepsy and Behavior. 2004 Dec;5(6):841-6

Fargo, J. D., Schefft, B. K., Dulay, M. F., Privitera, M. D., & Yeh, H.-S. Confrontation naming in individuals with temporal lobe epilepsy: A quantitative analysis of paraphasic error subtypes. Neuropsychology, 2005;19: 603-611.

Goldberg-Stern H, Gadoth N, Ficker D, Privitera M, et al. The effect of age and structural lesions on postictal language impairment. Seizure2005;14:62-5.

Griffith NM, Szaflarski JP, Szaflarski M, Kent GP, Schfft BK, Howe SR,  Privitera MD. Measuring depressive symptoms among treatment-resistant seizure disorder patients: POMS Depression scale as an alternative to the BDI-II. Epilepsy & Behavior 2005;7(2):266-72.

Ficker DM, Privitera M, Krauss G, Manner A, Moore JL, Glauser T. Improved tolerability and efficacy in epilepsy patients with extended-release carbamazepine. Neurology (2005) Aug 23;65(4);593-5.

Arroyo S, Dodson WE, Privitera MD, Glauser TA, Naritoku DK, Dlugos DJ, Wang S, Schwabe SK, Twyman RE for the EPMN-106/INT-28 Investigators.  Randomized dose-controlled study of topiramate as first-line therapy in epilepsy.  Acta Neurol Scand 2005.  (11) 214-222.

2006 through 2010

Privitera, M.  Large clinical trials in epilepsy:  funding by the NIH versus pharmaceutical industry.  Epilepsy Res., 2006 Jan,;68(1):52-6 Review.

Fargo, J.D., Schefft, B.K., Kent, G.P., Szaflarski, J.P., Privitera, M.D., Yeh, H.S. The prevalence of seizure syndromes among individuals referred for phase I neuropsychological assessment: Demographic and neuropsychological characteristics. The Clinical Neuropsychologist, 2006. DOI: 10.1080/13854040600611376; available online 10/13/06 at

Welty, TE, Faught, E, Privitera, MD.  Step therapy is not appropriate for antiepileptic drugs.  J. Manag Care Pharm. 2006 Apr;12(3):269-70 author reply 270-1.

Szaflarski, M., Meckler, J.M., Privitera, M.D., Szaflarski, J.P.  Quality of life in medication-resistant epilepsy:  The effects of patient’s age, age at seizure onset, and disease duration.  Epilepsy and Behavior, 2006, May; 8(3):547-51

Chadwick, D., Privitera, M.  How skeptical should we be about industry-sponsored studies?  Neurology. 2006 Aug 8;67(3):378-9.

Kent, GP, Schefft BK, Howe SR, Szaflarski JP, Yeh HS, Privitera MD “The effects of duration of intractable epilepsy on memory function” Epilepsy and Behavior 2006,9:469-477

Meador KJ, Baker GA, Finnell RH, Kalayjian LA, Liporace JD, Loring DW, Mawer G, Pennell PB, Smith JC, Wolff MC for the NEAD Study Group (Ficker DM, Privitera MD). In utero antiepileptic drug exposure: Fetal death and malformations. Neurology 2006;67:407-412.

Schefft, B., Kent, G., Howe, S., Szaflarski, J., Yeh, H., Privitera, M.  The effects of Seizure Duration on Memory Function.  Epilepsy and Behavior, 2006, Nov; 9(3)469-477.

Szaflarski, M., Szaflarski, J., Privitera, M., Ficker, D., Horner, R.  Racial/ethnic disparities in the treatment of epilepsy:  What do we know?  What do we need to know?  Epilepsy & Behavior   (2006) 9:243-264.

Testa SM, Schefft BK, Szaflarski JP, Yeh HS, Privitera MD.  Mood, Personality, and Health-related quality of Life in Epileptic and Psychogenic Seizure Disorders.  Epilepsia, 2007 Feb 5;

Griffith NM, Szaflarski JP, Schefft BK, Isaradisaikul D. Meckler JM, McNally KA, Privitera MD.  Relationship between semiology of psychogenic non-epileptic seizures and MMPI profile.  Epilepsy and Behavior 2007: 11: 105-11.

Szaflarski JP, Meckler JM, Szaflarski M, Shutter LA, Privitera MD, Yates SL.  Levetriacetam use in critically ill patients. Neurocrit Care, (2007) 7(2):140-7 

D’SouzaWJ, Fryer JL, Quinn SJ, Taylor BV, Ficker DM, O’Brien TJ, Pearce NE, Cook MJ. The Tasmanian epilepsy register – a community-based cohort: Background and methodology for patient recruitment from the Australian national prescription database. Neuroepidemiology. 2007;29:255-263.

Ramirez MJ, Schefft BK, Howe SR, Hwa-Shain Y, Privitera MD.  Interictal and postictal language testing accurately lateralizes language dominant temporal lobe complex partial seizures. Epilepsia (2008) Jan;49(1);22-32.

Fargo JD, Schefft BK, Szaflarski JP, Howe SR, Yeh HS, Privitera MD.  Accuracy of clinical neuropsychological versus statistical prediction in the classification of seizure types.  Clin. Neuropsychol. (2008) Mar; 22(2); 181-94.

Szaflarski JP, Holland SK, Jacola LN, Lindsell C. Privitera MD, Szaflarski M.  Comprehensive presurgical functional MRI language evaluation in adult patients with epilepsy. Epilepsy Behav. (2008) Jan;12(1); 74-83. Epub 12007 Oct 25.

Incorpora G, Pavone P, Ruggieri M. Cosuzza M, Mazzone L, Parano R, Privitera M.  Neonatal onset of hot water reflex siezures in monozygotic twins subsequently manifesting episodes of alternating hemiplegia.  Epilepsy Res. (2008) Feb; 78(2-3);225-31. Epub 2007 Dec 21.

Griffith NM, Smith KM, Schefft BS, Szaflarski JP, Privitera MP “Optimism, Pessimism, and Neuropsychological Performance Across Semiology-based Subtypes of Psychogenic Nonepileptic Seizures (PNES)” Epilepsy & Behavior 2008,13(3):478-484.

Vannest J. Szaflarski JP, Privitera MD, Schefft BK, Holland SK.  Medial temporal fMRI activation reflects memory lateralization and memory performance in patients with epilepsy.  Epliepsy Behav. (2008) Apr;12(3);410-8.

Meador KJ, et al (M Privitera).  Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs. NEJM 2009;360:1597-605

“NEAD Study Group (M. Privitera).  Antiepileptic Drug Use in Women of Childbearing Age.  Epilepsy and Behavior, 15, 2009:339-343.

Loyden Potter J, Schefft BK, Beebe DW, Howe SR, Yeh, HS, Privitera, MD. Presurgical Neuropsychological testing predicts cognitive and seizure outcome after anterior temporal lobectomy.  Epilepsy and Behavior 16 (2009), pp. 246-253

Chung S, Sperling MR, Biton V, Krauss G, Herbert D, Ridd GD, Doty P, SP754 Study Group.  Lacosamide as Adjunctive Therapy for Partial-onset Seizures: A randomized Controlled Trial.  Epilepsia. 2010 Jun;51(16):958-67.

Black LC, Schefft BK, Howe SR, Szaflarski JP, Yeh HS, Privitera MD.  The Effect of Seizures on Working Memory and Executive Functioning Performance.  Epilepsy Behav. 2010 Mar 17(3);412-9

Szaflarski J, Lindsell CJ, Banks C, Zakaria T, Privitera M.  Seizure control in patients with idiopathic generalized epilepsies – EEG determinants of medication response.  Epilepsy & Behavior. 2010 Apr;17(4):525-30.

Meador KJ, Penovich P, Baker GA, Pennell PB, Bromfield E, Pack A, Liporace JD, Sam M, Kalayjian LA, Thurman DJ, Moore E, Loring DW, for the NEAD Study Group.  Antiepileptic drug use in women of childbearing age.  Epilepsy and Behavior, 15 (2009) 339-343.

Ramirez MJ, Schefft BK, Howe SR, Hovanitz C, Yeh HS, Privitera MD.  The Effects of Perceived Emotional Distress on Language Performance in Intractable Epilepsy.  Epilepsy Behav. 2010 May;18(1-2):64-73

Ben-Menachem E, Sander JW, Privitera M, Gilliam F.  Measuring Outcomes of Treatment with Antiepileptic Drugs in Clinical Trials.  Epilepsy Behav. 2010 May;18(1-2):24-30.

Donnelly KM, Schefft BK, Howe SR, Szaflarski JP, Yeh HS, Privitera MD.  Moderating Effect of Optimism on Emotional Distress and Seizure Control in Adults with Temporal Lobe Epilepsy. Epilepsy Behav. 2010 Aug; 18(4):374-80

Szaflarski JP, Difrancesco M, Hirschauer T, Banks C, Privitera MD, Gotman J, Holland SK.  Cortical and Subcortical Contributions to Absence Seizure Onset Examined with EEG/fMRI.  Epilepsy Behav. 2010 Aug; 18(4):404-413

Ramsey E, Faught E, Krumholz A, Naritoku D, Privitera M, Schwarzman L, Mao L, Wiegand F, Hulihan J, for the CAPSS-272 Study Group.   Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: A randomized double-blind clinical trial.  Epilepsia.2010 Oct;51(10) 1970-7.

Privitera M, Kim KK.  Postictal Language Function.  Epilepsy Behav. 2010  Pct;19(2): 140-5.

2011 through 2015

Meador KJ, Baker GA, Browning N, Cohen MJ, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW,  for the NEAD Study Group.Fetal antiepileptic drug exposure and verbal versus non-verbal abilities at 3 years of age. Brain 2011 Feb;134(Pt2);396-404.

Meador, KJ; Baker GA, Browning N, Clayton-Smith J, Combs-Cantrell DT, Cohen M, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring D, NEAD Study Group. Effects of breastfeeding in children of women on antiepileptic drugs. Neurology 2010;75(22):1954-1960. NIHMS #327817.

Privitera, M.  Current Challenges in the Management of Epilepsy.  The American Journal of Managed Care, supplement, 2011;17(7):  S195 – S203.

Shafer PO, Buelow J, Ficker DM, Pugh MJ, Kanner AM, Dean P, Levisohn P. Risk of adverse events on epilepsy monitoring units: A survey of epilepsy professionals. Epilepsy Behav. 2011 Mar;20(3):502-5.

Kim KK, Karunanayaka P, Privitera MD, Holland SK, Szaflarski JP.  Semantic Association investigated with functional MRI and independent component analysis. Epilepsy Behav. 2011 Apr;20(4):613-22

Meador KJ, Baker GA, Browning N, Clayton-Smith J, Cohen MJ, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Loring DW.  Relationship of child IQ to parental IQ and education in children with fetal antiepileptic drug exposure.  Epilepsy Behav. 2011 Jun;21(2):147-52.

Privitera M. Is antiepileptic drug generic substitution always safe?  Slow progress toward definitive answers. Ann Neurol. 2011 Aug;70(2):192-3.

Cohen MJ, Meador KJ, Browning N, Baker GA, Clayton-Smith J, Kalayjian LA, Kanner A, Liporace JD, Pennell PB, Privitera M, Doring DW.  Fetal Antiepileptic drug exposure: motor, adaptive, and emotional/behavioral functioning at age 3 years. Epilepsy Behav. 2011 Oct;22(2):240-6.

Shafer PO, Buelow J, Ficker DM, Pugh MJ, Kanner AM, Dean P, Levisohn P. Risk of adverse events on epilepsy monitoring units: A survey of epilepsy professionals. Epilepsy Behav. 2011 Mar;20(3):502-5.

Ng YT, Conry JA, Drummond R, Stolle J, Weinberg MA; OV-1012 Study Investigators. (Ficker D). Randomized, phase III study results of clobazam in Lennox-Gastaut syndrome. Neurology. 2011 Oct 11;77(15):1473-81

Privitera M, de Los Rios la Rosa F.  Capecitabine-phenytion interaction is dose dependent with an unexpected time course. Anticancer Drugs. 2011 Nov;22(10):1027-9.

Kim KK, Privitera MD, Szaflarski JP.  Lessons learned from a comparison of language localization using fMRI and electrocortical mapping: case studies of neocortical epilepsy patients.  Epileptic Disord. 2011 Dec;13(4):368-74.

Kimford J. Meador, Gus Baker, Nancy Browning, Morris Cohen, Rebecca Bromley, Jill Clayton-Smith, Laura Kalayjian, Andres Kanner, Joyce Liporace, Page Pennell, Michael Privitera, and David W. Loring.  Effects of Fetal Antiepileptic Drug Exposure: Age 4.5 Year Outcomes. Neurology 2012 Apr 17;78(16):1207-14.

Pennell PB, Klein AM, Browning N, Baker GA, Clayton-Smith J, Kalayjian LA, Liporace JD, Privitera M, Crawford T, Loring DW, Meador KJ; NEAD Study Group.  Differential Effects of Antiepileptic Drugs on Neonatal Outcomes. Epilepsy and Behavior 2012 Aug:24(4):449-56.

Szaflarski JP, Gotman J, Privitera MD, Holland SK.  The relationship between the localization of the generalized spike and wave discharge generators and the response to valproate. In Press. Epilepsia.

D’Souza WJ, Quinn SJ, Fryer JL, Taylor BV, Ficker DM, O’Brien TJ, Pearce N, Cook MJ. The prevalence and demographic distribution of treated epilepsy: a community-based study in Tasmania, Australia. Acta Neurol Scand. 2012 Feb;125(2):96-104.

Silbergleit R, Durkalski V, Lowenstein D, Conwit R, Pancioli A, Palesch Y, Barsan W; NETT Investigators (Ficker D). Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012 Feb 16;366(7):591-600.

Shafer PO, Buelow JM, Noe K, Shinnar R, Dewar S, Levisohn PM, Dean P, Ficker D, Pugh MJ, Barkley GL. A consensus-based approach to patient safety in epilepsy monitoring units: Recommendations for preferred practices. Epilepsy Behav. 2012 Nov;25(3):449-56.

Moseley BD, Nickels K, Britton J, Wirrell E (2010).   How common is ictal hypoxemia and bradycardia in children with partial complex and generalized convulsive seizures?  Epilepsia, 51 (7), 1219 Co-Author

Moseley, Brian D; Ghearing, Gena R; Munger, Thomas M; Britton, Jeffrey W (2011). The treatment of ictal asystole with cardiac pacing. Epilepsia, 52 (4), e16-9 DOI: 10.1111/j.1528-1167.2010.02972.x

Moseley, Brian D; Wirrell, Elaine C; Nickels, Katherine; Johnson, Jonathan N; Ackerman, Michael J; Britton, Jeffrey (2011).   Electrocardiographic and oximetric changes during partial complex and generalized seizures. Epilepsy Research, 95 (3), 237-45 DOI: 10.1016/j.eplepsyres.2011.04.005

Moseley, Brian D; Ghearing, Gena R; Benarroch, Eduardo E; Britton, Jeffrey W (2011). Early seizure termination in ictal asystole.  Epilepsy Research, 97 (1-2), 220-4 DOI: 10.1016/j.eplepsyres.2011.08.008

Moseley, Brian D; Sinha, Shobhit; Meyer, Fredric B; Marsh, W Richard; Britton, Jeffrey W (2012). Long term outcomes in patients with preoperative generalized interictal epileptiform abnormalities following amygdalohippocampectomy. Epilepsy Research, 99 (1-2), 171-5 DOI: 10.1016/j.eplepsyres.2011.10.007

Moseley, Brian D; Nickels, Katherine; Wirrell, Elaine C (2012). Surgical outcomes for intractable epilepsy in children with epileptic spasms.  Journal of Child Neurology, 27 (6), 713-20 DOI: 10.1177/0883073811424463

Moseley, Brian D; Smith, Jonathan H; Diaz-Medina, Gloria E; Paz Soldan, M Mateo; Wicklund, Meredith; Dhamija, Radhika; Reda, Haatem; Presti, Michael F; Britton, Jeffrey W (2012). Standardized sign-out improves completeness and perceived accuracy of inpatient neurology handoffs.  Neurology, 79 (10), 1060-4 DOI: 10.1212/WNL.0b013e318265a698

Moseley, Brian D; Britton, Jeffrey W; Nelson, Cindy; Lee, Ricky W; So, Elson (2012). Periictal cerebral tissue hypoxemia: a potential marker of SUDEP risk. Epilepsia, 53 (12), e208-11 DOI: 10.1111/j.1528-1167.2012.03707.x

Polak, Emily L; Privitera, Michael D; Lipton, Richard B; Haut, Sheryl R (2012). Behavioral intervention as an add-on therapy in epilepsy: designing a clinical trial.  Epilepsy & Behavior: E&B, 25 (4), 505-10 DOI: 10.1016/j.yebeh.2012.09.012

Moseley, Brian; Bateman, Lisa; Millichap, John J; Wirrell, Elaine; Panayiotopoulos, Chrysostomos P (2013).  Autonomic epileptic seizures, autonomic effects of seizures, and SUDEP.  Epilepsy & Behavior: E&B, 26 (3), 375-85 DOI: 10.1016/j.yebeh.2012.08.020

Knight, William A; Hart, Kimberly W; Adeoye, Opeolu M; Bonomo, Jordan B; Keegan, Shaun P; Ficker, David M; Szaflarski, Jerzy P; Privitera, Michael D; Lindsell, Christopher J (2013). The incidence of seizures in patients undergoing therapeutic hypothermia after resuscitation from cardiac arrest. Epilepsy Research, 106 (3), 396-402 DOI: 10.1016/j.eplepsyres.2013.06.018

Wilcox, Karen S; Dixon-Salazar, Tracy; Sills, Graeme J; Ben-Menachem, Elinor; White, H Steve; Porter, Roger J; Dichter, Marc A; Moshé, Solomon L; Noebels, Jeffrey L; Privitera, Michael D; Rogawski, Michael A (2013). Issues related to development of new antiseizure treatments. Epilepsia, 54 Suppl 4 24-34 DOI: 10.1111/epi.12296

French, Jacqueline A; White, H Steve; Klitgaard, Henrik; Holmes, Gregory L; Privitera, Michael D; Cole, Andrew J; Quay, Ellinor; Wiebe, Samuel; Schmidt, Dieter; Porter, Roger J; Arzimanoglou, Alexis; Trinka, Eugen; Perucca, Emilio (2013). Development of new treatment approaches for epilepsy: unmet needs and opportunities.  Epilepsia, 54 Suppl 4 3-12 DOI: 10.1111/epi.12294

Kaplan, Marcia J; Dwivedi, Alok K; Privitera, Michael D; Isaacs, Kelly; Hughes, Cynthia; Bowman, Michelle (2013). Comparisons of childhood trauma, alexithymia, and defensive styles in patients with psychogenic non-epileptic seizures vs. epilepsy: Implications for the etiology of conversion disorder.  Journal of Psychosomatic Research, 75 (2), 142-6 DOI: 10.1016/j.jpsychores.2013.06.005

Szaflarski, Jerzy P; Kay, Benjamin; Gotman, Jean; Privitera, Michael D; Holland, Scott K (2013). The relationship between the localization of the generalized spike and wave discharge generators and the response to valproate.  Epilepsia, 54 (3), 471-80 DOI: 10.1111/epi.12062

Kay, Benjamin P; DiFrancesco, Mark W; Privitera, Michael D; Gotman, Jean; Holland, Scott K; Szaflarski, Jerzy P (2013). Reduced default mode network connectivity in treatment-resistant idiopathic generalized epilepsy. Epilepsia, 54 (3), 461-70 DOI: 10.1111/epi.12057

Moseley, Brian D; Wirrell, Elaine C; Wong-Kisiel, Lily C; Nickels, Katherine (2013). Early onset epilepsy is associated with increased mortality: a population-based study. Epilepsy Research, 105 (3), 410-4 DOI: 10.1016/j.eplepsyres.2013.03.002

Moseley, Brian D; So, Elson; Wirrell, Elaine C; Nelson, Cindy; Lee, Ricky W; Mandrekar, Jay; Britton, Jeffrey W (2013). Characteristics of postictal generalized EEG suppression in children. Epilepsy Research, 106 (1-2), 123-7 DOI: 10.1016/j.eplepsyres.2013.05.007

Kay, Benjamin P; Holland, Scott K; Privitera, Michael D; Szaflarski, Jerzy P (2014). Differences in paracingulate connectivity associated with epileptiform discharges and uncontrolled seizures in genetic generalized epilepsy. Epilepsia, 55 (2), 256-63 DOI: 10.1111/epi.12486

Hartings, Jed A; Wilson, J Adam; Hinzman, Jason M; Pollandt, Sebastian; Dreier, Jens P; DiNapoli, Vince; Ficker, David M; Shutter, Lori A; Andaluz, Norberto (2014).  Spreading depression in continuous electroencephalography of brain trauma Spreading depression in continuous electroencephalography of brain trauma.  Annals of Neurology DOI: 10.1002/ana.24256

Moseley, Brian D; Britton, Jeffrey W (2014). Peri-ictal QYc changes are not associated with hypoxemia. Epilepsy Research, 108 (5), 982-5 DOI: 10.1016/j.eplepsyres.2014.03.016

Moseley BD, Britton JW, So E (2014). (In Press). Increased cerebral oxygenation precedes generalized tonic clonic seizures. Epilepsy Research, (108), 1671 Author

Moseley BD, Dewar S, Haneef Z, Stern JM. How long is long enough? The utility of prolonged inpatient video EEG monitoring. Epilepsy Research, 2015 Jan; 109:9-12. doi: 10.1016/j.eplepsyres. 2014.10.011. Epub 2014 Oct 28., Brian D; Sinha, Shobhit; Meyer, Fredric B; Marsh, W Richard; Britton, Jeffrey W (2012).

  • Print This Page
  • Make an Appointment: Schedule Now
  • FY2015 Annual Report

  • Educational Conferences

  • Hope Stories

    • Amanda’s Story: Back Behind the Wheel

      Amanda's Story: Back Behind the WheelAfter two antiepileptic drugs failed to control Amanda's seizures, she underwent testing to see whether she was a candidate for epilepsy surgery. She was, and the results have been something to celebrate.    ...
    • Deanna’s Story: Conquering Seizures

      Deanna's Story: Conquering SeizuresDeanna was averaging three seizures a week when she arrived at the UC Gardner Neuroscience Institute. Sometimes her seizures caused her to pass out, and sometimes they left her blinking and wondering where the time had gone. Complicating her situation,...
    • Ryan’s Story: Epilepsy Surgery

      Ryan's Story: Epilepsy Surgery Ryan had reached one of the scariest points in his epilepsy – status epilepticus – when he and his team at the Epilepsy Center at the University of Cincinnati Gardner Neuroscience Institute knew that something dramatic needed to be done....
    • Scott’s Story: The Epilepsy Ambassador

      Scott's Story: The Epilepsy AmbassadorScott was working his dream job as a commercial airline pilot 10 years ago when his life was forever changed by epilepsy. After coming home from a long run, he complained of nausea and then collapsed with a grand mal...
    • Charlie’s Story: Epilepsy

      Charlie's Story: EpilepsyBy Charlie Shor I have had many adventures in my 57 years, and I have accomplished much. But the main message of my story, which I have been given the opportunity to share, is that anything is possible. If you have...